MS Tallman, JW Andersen, CA Schiffer, FR … - New England Journal of Medicine, 1997 - content.nejm.org Results Of the 174 patients treated with chemotherapy, 120 (69 percent) had a
complete remission, as did 124 of the 172 (72 percent) given all-trans-retinoic
acid (P = 0.56). When both induction and maintenance treatments were taken ... Cited by 544 - Related articles - BL Direct - All 8 versions
- ►hematologylibrary.org P Fenaux, C Chastang, S Chevret, M Sanz, H … - Blood, 1999 - bloodjournal.hematologylibrary.org All transretinoic acid (ATRA) followed by daunorubicin (DNR)-AraC chemotherapy
(CT) has improved the outcome of acute promyelocytic leukemia (APL) by
comparison to CT alone. In a randomized trial, (1) we compared 2 induction ... Cited by 402 - Related articles - BL Direct - All 11 versions
- ►hematologylibrary.org - Free from Publisher F Mandelli, D Diverio, G Avvisati, A Luciano, … - Blood, 1997 - bloodjournal.hematologylibrary.org From Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia,
University "La Sapienza," Rome; Clinica Pediatrica, Ospedale S. Gerardo,
University of Milano-Monza; Divisione di Ematologia, Ospedali Riuniti di ... Cited by 325 - Related articles - BL Direct - All 6 versions
- ►hematologylibrary.org - Free from Publisher MS Tallman, C Nabhan, JH Feusner, JM … - Blood, 2002 - bloodjournal.hematologylibrary.org Although early phase II trials showed a high CR rate with ATRA alone, the
remission durations were short. 18-21 Furthermore, some patients treated with
ATRA alone developed a rapid increase in WBC count that in some, but not ... Cited by 286 - Related articles - BL Direct - All 8 versions
- ►hematologylibrary.org - Free from Publisher MA Sanz, G Martin, C Rayon, J Esteve, M … - Blood, 1999 - bloodjournal.hematologylibrary.org The Spanish PETHEMA group designed a protocol for newly diagnosed PML/RAR
-positive acute promyelocytic leukemia (APL) in which induction and
consolidation followed the original AIDA regimen, except for the omission ... Cited by 236 - Related articles - BL Direct - All 6 versions
C Chastang, S Castaigne, P Fenaux - Blood, 1995 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 237 - Related articles - View as HTML - BL Direct - All 10 versions
- ►hematologylibrary.org - Free from Publisher AK Burnett, D Grimwade, E Solomon, K … - Blood, 1999 - bloodjournal.hematologylibrary.org All-trans retinoic acid (ATRA) is an essential component of the treatment of
acute promyelocytic leukemia (APL), but the optimal timing and duration remain
to be determined. Molecular characterization of this disease can refine the ... Cited by 236 - Related articles - BL Direct - All 9 versions
- ►nevada.edu [PDF] JS Menell, GM Cesarman, AT Jacovina, MA … - New England Journal of Medicine, 1999 - content.nejm.org Results The expression of annexin II, as detected by a fluorescein-tagged
antibody, was greater on leukemic cells from patients with APL than on other
types of leukemic cells (mean fluorescence intensity, 6.9 and 2.9, ... Cited by 225 - Related articles - BL Direct - All 9 versions
- ►hematologylibrary.org D Diverio, V Rossi, G Avvisati, S DeSantis, A … - Blood, 1998 - bloodjournal.hematologylibrary.org Although the majority of patients with acute promyelocytic leukemia (APL) are
potentially cured by treatments combining all-trans retinoic acid (ATRA) and
chemotherapy (CHT), a sizable proportion (around 30%) will relapse during ... Cited by 185 - Related articles - BL Direct - All 8 versions
